Tag: novo_nordisk
-
Media Monitor: Drugmakers Say Weight-Loss Medications May Slow Biological Aging
MIT Technology Review reports Eli Lilly and Novo Nordisk say GLP-1 weight-loss drugs reduced patients' biological age by roughly two to three years in molecular "aging clock" studies.
HealthBusinessScience & TechnologyMedical ScienceEconomyLegal MIT Technology ReviewGLP-1 drugsbiological agingaging clocksNovo NordiskEli LillysemaglutideMITsciencetechnology